H-D-Tle-OH

Catalog No.: 
ACUMHA295
CAS No.: 
26782-71-8
Molecular Formula: 
C6H13NO2
Molecular Weight: 
131.18
H-D-Tle-OH structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g97%$159.00In stockInquiry
500g97%$795.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameH-D-Tle-OH
IUPAC Name(R)-2-amino-3,3-dimethylbutanoic acid
MDL No.MFCD00004265
Molecular FormulaC6H13NO2
Molecular Weight131.18
SMILESN[C@H](C(C)(C)C)C(=O)O
InChI KeyNPDBDJFLKKQMCM-BYPYZUCNSA-N
Synonym(R)-2-Amino-3,3-dimethylbutyric acid | D-tert-Leucine, 98% | D-Valine, 3-methyl- | AC-24096 | BCP09236 | AM20090329 | (r)-tert-leucine | D-t-Butylglycine | (2R)-2-amino-3,3-dimethylbutyric acid | AKOS006240276 | UNII-P3L3QZA16M | (r)-tert-butylglycine | (
CAS No.26782-71-8
PubChem CID6950340

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACUMHA295 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWEUY871 route compound structure diagram
    ACWEUY87133105-81-6In Stock
  2. Plus
  3. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACUMHA295 route product structure diagram
    ACUMHA29526782-71-8In Stock
Inquiry

2. ACUMHA295 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHBDQ547 route compound structure diagram
    ACHBDQ54770874-05-4In Stock
  2. Then
  3. ACUMHA295 route product structure diagram
    ACUMHA29526782-71-8In Stock
Inquiry

3. ACUMHA295 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUMHA295 route product structure diagram
    ACUMHA29526782-71-8In Stock
Inquiry

Comments (0)